Intensive treatment with statins Offer a benefit farther than of the cholesterol in the reduction of cardiovascular events?

2006, Number 2

Rev Endocrinol Nutr 2006; 14 (2)

González GG

Language: Spanish
References: 6
Page: 114-116
PDF size: 85.72 Kb.

Text Extraction

No abstract

REFERENCES

Baigent C, Keech A, Kearney PM. Efficacy and safety of cholesterol lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomized trials of statins. Lancet 2005; 366: 1267-1278.
Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of Cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomized placebo controlled trial. Lancet 2002; 360: 7-22.
Cannon CP, Braunwald E, McCabe CH et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 2004; 350: 1495-1504.
de Lemos JA, Blazing MA, Wiviott SD et al. Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial. JAMA 2004; 292: 1307-1316.
LaRosa JC, Grundy SM, Waters DD at al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 2005; 352: 1425-1435.
Pedersen TR, Faergeman O, Kastelein JJP et al. Highdose atorvastatin versus usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial. JAMA 2005; 294: 2437-2445.